Protagonist Therapeutics, Inc. Recorded Big Gain
Mon, Oct 11, 2021 at 05:30 PM
Protagonist Therapeutics, Inc. (PTGX:NASDAQ) soared at $35.36, a gain of 93.9%. The stock got featured on our News Catalysts scanner on Mon, Oct 11, 2021 at 02:08 PM in the 'BIOTECH' category. From Fri, Sep 24, 2021, the stock recorded 60.00% Up Days and 63.64% Green Days
The share price of the company has been moving sideways in recent weeks.
About Protagonist Therapeutics, Inc. (PTGX:NASDAQ)
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.
Top 10 Gainers:
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 93.86%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 75.05%
- Flexion Therapeutics, Inc. (FLXN:NASDAQ), 58.65%
- PROG (PROG:NASDAQ), 58.52%
- U.S. Well Services, Inc. (USWS:NASDAQ), 25.83%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 23.97%
- Sphere 3D Corp. (ANY:NASDAQ), 23.77%
- GOTU (GOTU:NYSE), 19.35%
- Blue Apron Holdings, Inc. (APRN:NYSE), 17.4%
- Hexindai Inc. (HX:NASDAQ), 15.44%